![]() |
|||||||||||
![]() |
|||||||||||
Campus IRB Review Process
The Department of Health and Human Services (DHHS) recognizes that not all research proposals pose greater than minimal risk and warrant review by a convened Full Board Committee. Accordingly, the DHHS regulations permit the Campus IRB to review lower-risked research proposals posing at levels other than by the full board. The Initial Review Process authorizes the Campus IRB to categorize the proposed activities at the "Exempt", "Expedited" and "Full board" levels in an effort to appropriately assess the risks in relation to the benefits of participation. The initial review process is a one-time determination of the proposal risk assessment at that time, however, subsequent review proposals may result in a different review category allocation depending on the proposed risks to subject participants and interpretative IRB guidelines. What are the Levels of Review?
Assessment of Scientific MeritThe investigator shall assure the proposed activities have scientific merit. All research proposals reviewed by the Campus Institutional Review Board (Campus IRB) shall undergo a rigorous review to assess the scientific quality, importance of the research to increase knowledge, and the appropriateness of the study methodology to answer a precisely articulated scientific question. The Campus IRB Scientific Members will provide the membership with their review of the scientific merit and feasibility of the proposal.
Assessing the Level of RiskAll human research proposals will be reviewed to assess the level of risk in relation to the benefit afforded to the subject from participation in the proposed activities. The Campus IRB will make an assessment as to whether the research poses greater than minimal risk, and if the proposed methods adequately minimize the risk to subject participants. The level of risk is assessed on a case-by-case basis and shall accurately reflect the foreseeable risks as a result of participation.
ProcessesThe Campus IRB regularly reviews and approves applications and continuing review status reports of previously approved projects. All continuing reviews must be conducted at least once per year, and may be required as frequently needed as the degree of risk to the subject participants mandates. The investigator should submit an application to the Campus IRB for initial review and approval of the proposed activities.
AmendmentFederal regulations require the Campus IRB to develop processes for ensuring prompt reporting to the IRB of changes in previously approved research activities. Investigators may not initiate modifications to human research activities without the prospective review and approval from the Campus IRB except where necessary to eliminate apparent immediate hazards to the human subjects. In such a case, the research team should contact the IRB immediately for directives.
Continuing Review PolicyThe Campus IRB assures that all human subject research conducted under its jurisdiction is afforded the opportunity for renewal in the form of a continuation review process. The required Continuing Review Status Report must be submitted 45 days prior to the project expiration date to avoid the risk of delays in the review process or expiration of IRB approval. Reports received after the required 45 date deadlines are not guaranteed to be reviewed prior to the expiration date. Investigators should comply with the 45 day submission deadline to avoid interruptions in the IRB approval term. Reports received after the expiration date will not be reviewed and IRB approval will automatically expire. If the investigator intends to continue to conduct research, they must contact the IRB immediately for directives regarding the "Application Submission Process" and what activities must cease. When considering whether or not to renew a study, the CIRB will review the CRR report, all supportive documents, and the investigator's responses to determine that:
DeviationUnforeseen circumstances may arise that require a researcher to deviate from the IRB approved methodology, in the best interest of the safety of a human subject research participant. The researcher shall grant top priority to assuring the subject's safety and welfare and then immediately contact to the Campus IRB for compliance directives. The research team must complete
Unanticipated Problems or Adverse Events Causing Harm to Participants or OthersThe Campus Institutional Review Board (Campus IRB) has established policies and procedures for ensuring prompt reporting to the IRB and appropriate institutional officials regarding unanticipated problems or adverse events causing harm to participants or others in accordance with State, Federal and local law. The investigator shall ensure prompt reporting to the IRB, appropriate institutional officials, sponsor, coordinating center and the appropriate regulatory agency heads of unanticipated problems or adverse events causing harm to participants or others.
Non-ComplianceThe Campus Institutional Review Board (Campus IRB) is required to provide a mechanism to immediately investigate reports of noncompliance to further protect study participants, and shall have the authority to take action to assure research activities are conducted in accordance with the regulations that govern human subject research. The Campus IRB considers noncompliance as potentially one of the highest risks exposed to subjects. Reports or notice of noncompliance shall receive priority consideration and review by the Campus IRB with the goal of assuring human subjects are protected. Investigators shall ensure all human subject research activities comply with Campus IRB policies.
Suspensions and TerminationsThe convened IRB or IRB designee may order a suspension or termination of approved research when in the judgment of the convened IRB or IRB designee, it is in the best interest to protect the rights or welfare of participants. Conflicts of InterestIdentification and management of a conflict of interest is an important step in the IRB. The Campus IRB requires the investigator to comply with institutional "disclosure methods" that may potentially affect human subjects to facilitate preserving the integrity of the IRB processes. The investigator must disclose a conflict of interest in the following situations, but not limited to:
|
|||||||||||
|
|||||||||||

